Advertisement

Topics

Boston Scientific Announces Acquisition Of nVision Medical Corporation

06:30 EDT 16 Apr 2018 | Boston Scientific

Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health. nVision developed the first and only device cleared by the U.S. Food and Drug Administration to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. Recent studies have confirmed that several major types of ovarian cancer appear to originate from the fallopian tubes.1 Ovarian cancer is the...

Original Article: Boston Scientific Announces Acquisition Of nVision Medical Corporation

NEXT ARTICLE

More From BioPortfolio on "Boston Scientific Announces Acquisition Of nVision Medical Corporation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...